全文获取类型
收费全文 | 1278篇 |
免费 | 85篇 |
国内免费 | 42篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 34篇 |
妇产科学 | 21篇 |
基础医学 | 163篇 |
口腔科学 | 18篇 |
临床医学 | 168篇 |
内科学 | 243篇 |
皮肤病学 | 21篇 |
神经病学 | 80篇 |
特种医学 | 207篇 |
外科学 | 134篇 |
综合类 | 20篇 |
一般理论 | 3篇 |
预防医学 | 97篇 |
眼科学 | 3篇 |
药学 | 55篇 |
中国医学 | 1篇 |
肿瘤学 | 123篇 |
出版年
2021年 | 14篇 |
2019年 | 10篇 |
2018年 | 19篇 |
2017年 | 10篇 |
2016年 | 12篇 |
2015年 | 24篇 |
2014年 | 24篇 |
2013年 | 34篇 |
2012年 | 38篇 |
2011年 | 51篇 |
2010年 | 39篇 |
2009年 | 38篇 |
2008年 | 43篇 |
2007年 | 52篇 |
2006年 | 36篇 |
2005年 | 48篇 |
2004年 | 32篇 |
2003年 | 35篇 |
2002年 | 29篇 |
2001年 | 29篇 |
2000年 | 31篇 |
1999年 | 33篇 |
1998年 | 43篇 |
1997年 | 39篇 |
1996年 | 41篇 |
1995年 | 35篇 |
1994年 | 50篇 |
1993年 | 29篇 |
1992年 | 17篇 |
1991年 | 16篇 |
1990年 | 21篇 |
1989年 | 49篇 |
1988年 | 46篇 |
1987年 | 51篇 |
1986年 | 40篇 |
1985年 | 31篇 |
1984年 | 28篇 |
1983年 | 18篇 |
1982年 | 11篇 |
1981年 | 11篇 |
1980年 | 9篇 |
1978年 | 9篇 |
1977年 | 7篇 |
1976年 | 9篇 |
1975年 | 7篇 |
1973年 | 11篇 |
1970年 | 9篇 |
1969年 | 6篇 |
1967年 | 8篇 |
1966年 | 6篇 |
排序方式: 共有1405条查询结果,搜索用时 0 毫秒
1.
The impact of percutaneous transluminal angioplasty on the management of peripheral vascular disease 总被引:1,自引:0,他引:1
J B Anderson A P Wolinski I P Wells D C Wilkins B P Bliss 《The British journal of surgery》1986,73(1):17-19
Percutaneous transluminal angioplasty is a well established technique with wide application, but its place in the overall management of peripheral vascular disease is not well defined. This study compares similar groups of patients with peripheral vascular disease in 1981 and 1984, before and after the introduction of the technique to a district general hospital. More patients are now being investigated and treated and this is almost entirely due to the availability of angioplasty. The rates for surgery have not changed. Percutaneous transluminal angioplasty should therefore be seen as a new and separate form of treatment for peripheral vascular disease, not necessarily influencing or replacing surgery, and requiring its own allocation of resources in accordance with the increase in the level of care afforded by the technique. 相似文献
2.
Primary squamous cell carcinoma is an extremely rare tumour of the thyroid gland. A case of an elderly lady who was diagnosed to have primary squamous cell carcinoma of the thyroid gland is presented and the role of radiotherapy is discussed. 相似文献
3.
A retrospective analysis of treatment for endometrial carcinoma is reported here. From 1987 to 1989, 138 patients were referred to the oncology department following total abdominal hysterectomy and bilateral salpingo-oophorectomy for endometrial cancer. Forty-seven patients were not prescribed postoperative radiotherapy; 31 had Stage I well differentiated adenocarcinoma with minimal myometrial invasion, while the remaining 16 patients were considered unfit for postoperative radiotherapy. There were no instances of local relapse amongst the 31 patients with minimal myometrial invasion.The remaining 91 patients all received external beam irradiation to the pelvis and, according to the preference of the individual therapist, 51 were prescribed additional intracavitary vault caesium-137. Patients receiving postoperative radiotherapy were analysed according to whether or not they received additional intracavitary vault caesium. The two groups were also analysed for incidence of vaginal vault recurrence and treatment related morbidity.In the group receiving additional intracavitary treatment more patients had Stage II or III disease (P<0.05), and had greater depth of myometrial invasion (P<0.05). Vaginal vault recurrence was not observed in patients receiving intracavitary therapy in addition to external beam therapy. Four patients (10%) receiving external beam therapy alone developed vaginal vault recurrence.The incidence of Kottmeier-Perez grade 2 or 3 bowel toxicity following treatment was significantly higher in those patients receiving combined treatment (18% vs. 2.5%; P<0.03). There was also a higher incidence of vaginal stenosis in the group receiving both external beam and intracavitary therapy (21% vs. 3%; P<0.05). There was only one instance of grade 2 bladder toxicity in the external beam and intracavitary treatment group and none in the external beam therapy alone group.In conclusion, postoperative radiotherapy for Stages I-III endometrial carcinoma was carried out in a non-randomized manner by two regimens; either external beam therapy alone or external beam therapy with additional intracavitary vaginal caesium. The combined therapy gave significantly better local control but resulted in significantly more late bowel and vaginal morbidity. 相似文献
4.
Monitors in nutrition support. 总被引:1,自引:0,他引:1
Donna Zimmaro Bliss 《Nutrition in clinical practice》2004,19(5):421-422
5.
6.
高效液相色谱法测定右旋儿茶素血浆浓度及药代动力学参数 总被引:1,自引:0,他引:1
本文建立了体液中右旋儿茶素的RP-HPLC测定方法。采用C_(18)键合相硅胶为填料的固相提取柱进行样品预处理,右旋儿茶素的提取回收率为79.8%.应用二极管阵列检测器对色谱峰纯度进行鉴定。该法精密度好,方法回收率近100%,日内、日间的变异系数为2.4~5.6%,血浓69.6~1160 ng/ml范围内呈线性关系,r=0.9993。家兔静注右旋儿茶素18mg/kg,其药代动力学过程符合二室模型,分布相半衰期为0.129 h,消除相半衰期为1.19h。 相似文献
7.
石杉碱甲类似物的研究II.N-甲基吡啶酮石杉碱甲类似物的合成 总被引:4,自引:1,他引:3
石杉碱甲(1)是从中草药石杉属植物千层塔(Lycopodium serratum Thunb.)中分得的一种高效可逆的乙酰胆碱酯酶抑制剂,临床试验证实它对早老性痴呆症有显著疗效。本文报道N-甲基吡啶酮石杉碱甲类似物2和3的合成。2-甲氧基-5-甲氧羰基-11-亚甲基-5,9-甲撑环辛-7-烯并吡啶(9)在乙腈中用三甲基氯硅烷和碘化钠选择性脱保护以定量的产率得吡啶酮10,再用甲醇钠和碘甲烷甲基化得N-甲基吡啶酮11,11经碱性水解,Curtius重排和氨基的脱保护得N-甲基吡啶酮石杉碱甲类似物2。通过类似的途径从中间体2-甲氧基-5-甲氧羰基-7-甲基-11-酮-5,9-甲撑环辛-7-烯并吡啶(14)合成了类似物3。类似物2和3的乙酰胆碱酯酶抑制活性均低于天然石杉碱甲。 相似文献
8.
9.
Sleep loss and cerebral excitability 总被引:2,自引:0,他引:2
10.
New health practitioners (NHPs) is a generic term referring to mid-level health workers such as physician's assistants and nurse practitioners who perform tasks traditionally within the purview of physicians. In the little over ten years since the first program to train physician assistants was initiated at Duke University, 6,500 physician's assistants (PAs) have completed formal training programs. Similarly, programs to train nurses for extended roles have prepared more than 8,500 nurse practitioners over the same decade. This paper considers the comparative achievements of these two major new health professions during the last decade and identifies eight crucial issues which may influence new health professionals in the ten years which lie ahead: (1) How many NHPs are enough? (2) What impact are NHPs making on distribution? (3) Do we know what clinical difference NHPs make? (4) Are NHPs bringing about cost control in health care? (5) What is the status of the controversy between organized medicine and nursing with regard to NHPs? (6) Are there differences between nurse practitioners and physician's assistants? (7) How are NHPs certified? and (8) Finally, can a better name than "new health practitioners" be found? 相似文献